Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Ryan

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Frontline Gastroenterology|November 5, 2019
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic healthAhmad Moolla, Kenzo Motohashi, Thomas Marjot, et al.
Gut|June 4, 2021
Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infectionClare Elizabeth Foley, Christopher Mulvey, Maria Boylan, et al.
The Journal of Infectious Diseases|March 17, 2025
Non-invasive monitoring of humoral immune responses in men with acute Chlamydia trachomatis urethral infection using first-catch urineJohn D Ryan, Caleb M Ardizzone, Stephen J Jordan, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2020
Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosisBhavika Parmanand, Michael Watson, Karen J Boland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 6, 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patientsJohn D Ryan, Andrew E Armitage, Jeremy F Cobbold, et al.
Journal of Clinical Pathology|May 30, 2023
Tumour stemness and poor clinical outcomes in haemochromatosis patients with hepatocellular carcinomaDaniel M Di Capua, William Shanahan, Michele Bourke, et al.
Ebiomedicine|January 15, 2019
PYY plays a key role in the resolution of diabetes following bariatric surgery in humansClaudia Guida, Sam D Stephen, Michael Watson, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisStephan Buch, Aneesh Sharma, Eleanor Ryan, et al.
Nature Reviews. Endocrinology|December 14, 2023
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemiaLuca Valenti, Elena Corradini, Leon A Adams, et al.
Nature Reviews. Endocrinology|February 22, 2023
Consensus Statement on the definition and classification of metabolic hyperferritinaemiaLuca Valenti, Elena Corradini, Leon A Adams, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Frontline Gastroenterology|November 5, 2019
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic healthAhmad Moolla, Kenzo Motohashi, Thomas Marjot, et al.
Gut|June 4, 2021
Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infectionClare Elizabeth Foley, Christopher Mulvey, Maria Boylan, et al.
The Journal of Infectious Diseases|March 17, 2025
Non-invasive monitoring of humoral immune responses in men with acute Chlamydia trachomatis urethral infection using first-catch urineJohn D Ryan, Caleb M Ardizzone, Stephen J Jordan, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2020
Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosisBhavika Parmanand, Michael Watson, Karen J Boland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 6, 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patientsJohn D Ryan, Andrew E Armitage, Jeremy F Cobbold, et al.
Journal of Clinical Pathology|May 30, 2023
Tumour stemness and poor clinical outcomes in haemochromatosis patients with hepatocellular carcinomaDaniel M Di Capua, William Shanahan, Michele Bourke, et al.
Ebiomedicine|January 15, 2019
PYY plays a key role in the resolution of diabetes following bariatric surgery in humansClaudia Guida, Sam D Stephen, Michael Watson, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisStephan Buch, Aneesh Sharma, Eleanor Ryan, et al.
Nature Reviews. Endocrinology|December 14, 2023
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemiaLuca Valenti, Elena Corradini, Leon A Adams, et al.
Nature Reviews. Endocrinology|February 22, 2023
Consensus Statement on the definition and classification of metabolic hyperferritinaemiaLuca Valenti, Elena Corradini, Leon A Adams, et al.
Pageof 6